Nutrien Ltd (NTR) concluded trading on Wednesday at a closing price of $49.93, with 3.85 million shares of worth about $192.04 million changed hands on the day. Half year performance of the stock remained positive as price took a surge of 8.14% during that period and on February 12, 2025 the price saw a loss of about -3.52%. Currently the company’s common shares owned by public are about 493.88M shares, out of which, 493.12M shares are available for trading.
Stock saw a price change of -3.52% in past 5 days and over the past one month there was a price change of -2.48%. Year-to-date (YTD), NTR shares are showing a performance of 11.58% which increased to 1.67% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $43.69 but also hit the highest price of $60.87 during that period. The average intraday trading volume for Nutrien Ltd shares is 2.10 million. The stock is currently trading -3.77% below its 20-day simple moving average (SMA20), while that difference is up 1.99% for SMA50 and it goes to 0.11% higher than SMA200.
Nutrien Ltd (NYSE: NTR) currently have 493.88M outstanding shares and institutions hold larger chunk of about 73.76% of that.
The stock has a current market capitalization of $24.64B and its 3Y-monthly beta is at 0.85. PE ratio of stock for trailing 12 months is 33.71, while it has posted earnings per share of $1.48 in the same period. It has Quick Ratio of 0.82 while making debt-to-equity ratio of 0.59. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for NTR, volatility over the week remained 2.75% while standing at 2.47% over the month.
Digging deeper we find that several firms have released their research notes about the support levels of the stock. Most recent of them is a note released by Barclays on January 21, 2025 offering an Equal weight rating for the stock and assigned a target price range of between $55 and $56 to it. Coverage by Piper Sandler stated Nutrien Ltd (NTR) stock as an Overweight in their note to investors on January 13, 2025, suggesting a price target of $58 for the stock. On January 13, 2025, JP Morgan Upgrade their recommendations, while on December 03, 2024, Raymond James Upgrade their ratings for the stock with a price target of $60. Stock get a Neutral rating from UBS on October 10, 2024.
